Saba Capital reports 20.3% ECAT stake in BlackRock ESG Term Trust (NYSE: ECAT)
Rhea-AI Filing Summary
Saba Capital Management and related parties filed Amendment No. 33 to their Schedule 13D on BlackRock ESG Capital Allocation Term Trust. They report beneficial ownership of 20,188,874 Common Shares, representing 20.3% of the outstanding shares, based on 99,468,307 shares outstanding as of 12/31/25.
Saba’s funds and accounts paid approximately $300,116,072 in total to acquire these shares, using investor subscription proceeds, related capital appreciation, and ordinary-course margin borrowings. All recent trades from 4/27/26 through 5/8/26 were executed in the open market, and Saba-advised funds are entitled to dividends and sale proceeds on the shares.
Positive
- None.
Negative
- None.
Insights
Saba discloses a sizable 20.3% stake in ECAT.
Saba Capital and affiliates report owning 20,188,874 Common Shares of BlackRock ESG Capital Allocation Term Trust, equal to 20.3% of shares outstanding as of 12/31/25. The filing updates prior Schedule 13D disclosures with new ownership and funding details.
The total cost basis of about $300,116,072 reflects substantial capital committed via investor subscriptions, appreciation, and margin borrowings. All recent trades between 4/27/26 and 5/8/26 were open-market transactions, indicating position adjustments rather than a single block transaction.
The filing confirms that funds and accounts advised by Saba Capital receive dividends and sale proceeds on these shares. Future company and shareholder communications may clarify how this large ownership position influences voting outcomes and any interactions regarding the trust’s capital allocation or term structure.